Inflammatory subtypes in asthma.

• Conditions: Asthma; Eosinophilic asthma; Asthma subtypes; biomarker

• Registration Number: NL-OMON26030
• Lead Sponsor: Academisch Medisch Centrum (AMC) Amsterdam

Brief Summary

/A

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

1. Age >18 years;

2. Clinical presentation of asthma;

Exclusion Criteria

1. Change in the dose of ICS in 4 weeks prior to screening;

2. A course of oral corticosteroids, antibiotics or a respiratory infection within 4 weeks prior to the study;

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
eNose breathprint of eosinophilic and non-eosinophilic astma.

Secondary Outcome Measures

Name	Time	Method
Individual biomarkers and proteomic profiles in sputum, blood, urine, and nasal lavage, associated with eosinophilic asthma and non-eosinophilic asthma.